"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"
"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"
Pupillary dilation induced by mydriatic agents during Retinopathy of Prematurity exams can
 persist for hours. Despite regular use of eye protection for mydriatic-induced light
 sensitivity for infants, children and adults, eye protection after mydriasis has not been
 addressed in neonates. This study examines the use of eye patches to protect the dilated
 pupil from light exposure and their impact on vital signs and pain scores. prevents
 tachycardia, tachypnea and discomfort in neonates after ROP screening.
Pain management for Retinopathy of prematurity (ROP) screening focuses on pharmacological and
 non-pharmacological interventions during the actual eye examination. Management of pain
 related to increased light sensitivity during the post-mydriasis period has not been
 described.

 This prospective, randomized study evaluated the impact of protecting the eyes from ambient
 light exposure post mydriasis. Vital signs and pain scales were recorded in infants
 randomized to either wear or not wear eye patches after mydriasis for their ROP exam. Infants
 less than 30 weeks gestational age or less than 1500 grams at birth were included. Standard
 statistical methods were used to compare vital signs and pain scores for each group at
 baseline, 1 and 3 hours after mydriasis.
Inclusion Criteria:

 -  All infants with gestational age at birth of 30 weeks or less or with birth weight
 less than 1500g undergoing their first ROP exam in the Infant Special Care Unit (ISCU)
 at UTMB.

 Exclusion Criteria:

 -  Infants were excluded if they had any congenital malformation or syndrome; a history
 of eye surgery or were receiving inotropics medications.